Similar articles

• An important differential for ascending weakness.

  Brostoff JM, Pascu O, Hutchison BG. Brostoff JM, et al. Intern Med J. 2008 Sep;38(9):743-5. doi: 10.1111/j.1445-5994.2008.01776.x. Intern Med J. 2008. PMID: 19143894 No abstract available.
• Colchicine-induced myopathy in renal failure.

  Sinsawaiwong S, Phanthumchinda K, Jongpiputvanich S. Sinsawaiwong S, et al. J Med Assoc Thai. 1997 Oct;80(10):667-70. J Med Assoc Thai. 1997. PMID: 10904571
• Colchicine myoneuropathy in a renal transplant patient.

  Dupont P, Hunt I, Goldberg L, Warrens A. Dupont P, et al. Transpl Int. 2002 Jul;15(7):374-6. doi: 10.1007/s00147-002-0426-9. Epub 2002 Jun 20. Transpl Int. 2002. PMID: 12122515
• Colchicine use in cyclosporine treated transplant recipients: how little is too much?

  Simkin PA, Gardner GC. Simkin PA, et al. J Rheumatol. 2000 Jun;27(6):1334-7. J Rheumatol. 2000. PMID: 10852250 Review. No abstract available.
• Colchicine-Induced Myopathy in a Tacrolimus-Treated Renal Transplant Recipient: Case Report and Literature Review.

  Yousuf Bhat Z, Reddy S, Pillai U, Doshi M, Wilpula E. Yousuf Bhat Z, et al. Am J Ther. 2016 Mar-Apr;23(2):e614-6. doi: 10.1097/MJT.0000000000000044. Am J Ther. 2016. PMID: 24732905 Review.